Fedirko, V., McKeown-Eyssen, G., Serhan, C. N., Barry, E. L., Sandler, R. S., Figueiredo, J. C., . . . Baron, J. A. (2017). Plasma Lipoxin A(4) and Resolvin D1 are Not Associated with Reduced Adenoma Risk in a Randomized Trial of Aspirin to Prevent Colon Adenomas. Mol Carcinog.
Citação norma ChicagoFedirko, Veronika, et al. "Plasma Lipoxin A(4) and Resolvin D1 Are Not Associated With Reduced Adenoma Risk in a Randomized Trial of Aspirin to Prevent Colon Adenomas." Mol Carcinog 2017.
MLA citiranjeFedirko, Veronika, et al. "Plasma Lipoxin A(4) and Resolvin D1 Are Not Associated With Reduced Adenoma Risk in a Randomized Trial of Aspirin to Prevent Colon Adenomas." Mol Carcinog 2017.
Opozorilo: Ti citati niso vedno 100% točni.